Carmell Therapeutics' Series A - III Round

Carmell Therapeutics raised a round of funding on June 11, 2014. Investors include Keiretsu Forum.

Carmell Therapeutics is developing biologically-active medical devices manufactured from blood plasma with growth and regenerative factors designed by nature in the right proportions to heal tissues. …

Articles about Carmell Therapeutics' Series A - III Round: